FLT3LG and neoplasm: We observed that the “SUP3 + anti-PD-L1 + Flt3L” regimen exhibited stronger suppression of B16F10 tumor growth than the “PAM3 + anti-PD-L1 + Flt3L” combination (Fig. 7I and Supplementary Fig S9B).